Elrig

APRIL 7, 2025

In 2009, heco-founded the European arm of Essen BioScience, playing a pivotal role in developing industrial-scale, live-cell imaging technology for drug discovery. Previously, he heldsenior director positions at GlaxoSmithKline R&D, leading teams in biological reagents, assay development, and compound profiling.

Assay Development 59

Assay Development Laboratories Science Drugs 59

Drug Target Review

JUNE 15, 2023

Interested in a more disease-focused training for his postdoc, he pursued work in the National Institutes of Health (NIH), particularly in the National Center for Advancing Translational Sciences (NCATS), US. Sam focuses on the application of innovative assay development strategies to enable to interrogation of complex targets.

RNA 96

RNA Small Molecule Disease Assay Development 96

Drug Target Review

NOVEMBER 1, 2023

We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. I think as a researcher you have to be honest and transparent about your data, and always do the best science that you possibly can do.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

Drug Target Review

APRIL 7, 2025

PoLiPa technology Domainex’s Polymer Lipid Particle (PoLiPa) technology offers a versatile, detergent-free platform for the rapid, high-purity preparation of membrane proteins like GPCRs, ion channels and solute carriers, enabling assay development for these challenging targets.

Fragment Screening 52

Fragment Screening Drugs Small Molecule Biophysical Assays 52

Broad Institute

OCTOBER 17, 2023

Christian Soule is the associate director of automation in the Center for the Development of Therapeutics (CDoT) at the Broad Institute of MIT and Harvard, where he leads a team focused on the development and execution of assays for high-throughput screening. Soule holds a B.S. in mechanical engineering from Boston University.

Assay Development 52

Assay Development Laboratories Engineering Science 52

Elrig

APRIL 29, 2024

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. During this time, I had the opportunity to step in as an interim Discovery Sciences project lead, sparking my interest in project leadership.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Sygnature Discovery

FEBRUARY 11, 2022

This exciting partnership combines our novel assay development and hit identification expertise with River BioMedics unique, state-of-the-art technology: advanced human-predictive in vitro 3D heart models, plus their deep knowledge of cardiac biology.

Assay Development 52

Assay Development Disease Engineering Science 52